Related Subjects:
|Monoarticular arthritis
|Polyarticular arthritis
|Seronegative Spondyloarthropathies
|Ankylosing spondylitis
|Enteropathic Spondyloarthritis
|Reactive Arthritis
๐ฆด Psoriatic Arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis.
It belongs to the seronegative spondyloarthropathies (negative for RF/anti-CCP).
Presentation ranges from mild oligoarthritis to severe, deforming arthritis.
โ ๏ธ Severe PsA is more common in HIV-positive patients.
๐ About
- PsA is a seronegative arthritis (RF/anti-CCP negative).
- Psoriasis usually precedes arthritis, but PsA can occur before skin lesions.
- Affects both axial and peripheral skeleton.
๐งฌ Aetiology
- Affects men and women equally; peak age 30โ55 yrs.
- Genetic: HLA-B27, HLA-Cw6 association.
- Immune-mediated: T-cell and cytokine (TNF-ฮฑ, IL-17, IL-23) driven.
- Triggers: Trauma (Koebner phenomenon), infections, environmental exposures.
๐ Key Radiological Finding
๐๏ธ Pencil-in-Cup Deformity: end-bone erosion with tapering into adjacent bone cup, typical of advanced PsA.
๐ฉบ Clinical Features
- Skin ๐๏ธ: Psoriasis on scalp, elbows, knees, umbilicus, natal cleft, palms/soles.
- Nails ๐
: Pitting, onycholysis, โoil dropโ sign.
- Joints:
- Asymmetrical oligoarthritis (most common).
- Symmetrical polyarthritis (RA-like).
- DIP arthritis โ often with nail changes.
- Dactylitis = โsausage digitโ.
- Arthritis mutilans โ destructive, deforming.
- Axial disease with sacroiliitis, spinal stiffness.
- Extra-articular ๐: Pulmonary fibrosis, aortic regurgitation, anterior uveitis/conjunctivitis.
๐ Patterns of Joint Involvement
- ๐ DIP predominant (linked to nail disease).
- โ Asymmetrical oligoarthritis (knees, large joints).
- ๐คฒ Symmetrical polyarthritis (mimics RA).
- ๐ฆด Arthritis mutilans (rare, severe).
- ๐ง Axial arthritis (sacroiliitis, spine).
๐งพ CASPAR Criteria (โฅ3 points)
- Psoriasis (current = +2; past/family = +1).
- Nail dystrophy (pitting/onycholysis) = +1.
- Dactylitis (past or present) = +1.
- RF negative = +1.
- Juxta-articular new bone formation (X-ray) = +1.
๐งช Investigations
- Bloods: FBC (anaemia), โESR/CRP, RF/anti-CCP negative.
- Imaging:
- X-ray: erosions, joint narrowing, bony proliferation, periostitis, pencil-in-cup deformity.
- MRI: useful for sacroiliitis and early axial disease.
๐ Management of Psoriatic Arthritis (PsA)
- Principle: Early treatment using a treat-to-target approach to prevent joint damage and disability. Assess pattern first: peripheral, axial, enthesitis, dactylitis, skin-dominant.
- ๐ข Conservative & Lifestyle:
- Patient education and shared decision-making.
- Weight reduction (obesity reduces biologic response).
- Smoking cessation.
- Physiotherapy and exercise (maintain mobility and function).
- ๐ก Symptomatic Relief:
- NSAIDs for pain and stiffness (short term; monitor GI/CV risk).
- Intra-articular steroid injections for isolated joint inflammation.
- Systemic steroids used cautiously (risk of psoriasis rebound on withdrawal).
- ๐ Conventional DMARDs (peripheral disease):
- Methotrexate (first-line for peripheral arthritis and skin involvement).
- Sulfasalazine or Leflunomide as alternatives.
- Note: Conventional DMARDs have limited effect in axial disease.
- ๐ต Biologic / Targeted Therapy (moderateโsevere or inadequate response):
- Anti-TNF agents (e.g., etanercept, adalimumab, infliximab).
- IL-17 inhibitors (e.g., secukinumab, ixekizumab).
- IL-23 inhibitors (e.g., guselkumab).
- JAK inhibitors (e.g., upadacitinib) in selected patients.
- ๐ด Axial PsA:
- NSAIDs first-line.
- If persistent โ biologic therapy (anti-TNF or IL-17 inhibitor).
- Conventional DMARDs are generally ineffective for axial symptoms.
- ๐ง Monitor & Screen:
- Assess disease activity regularly (joints + skin).
- Screen for uveitis, IBD, metabolic syndrome, and cardiovascular risk.
Surgical: Joint replacement or synovectomy in advanced destructive disease.
๐ References